These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 27549772)

  • 21. Outcome of surgery for colorectal cancer in the presence of peritoneal carcinomatosis.
    Klaver YL; Lemmens VE; de Hingh IH
    Eur J Surg Oncol; 2013 Jul; 39(7):734-41. PubMed ID: 23523316
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Survival prognostic factors in patients with colorectal peritoneal carcinomatosis treated with cytoreductive surgery and intraoperative hyperthermic intraperitoneal chemotherapy: a single institution experience.
    Nikolic S; Dzodic R; Zegarac M; Djurisic I; Gavrilovic D; Vojinovic V; Kocic M; Santrac N; Radlovic P; Radosavljevic D; Pupic G; Martinovic A
    J BUON; 2014; 19(1):66-74. PubMed ID: 24659645
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of prognostic scores for patients with colorectal cancer peritoneal metastases treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
    Cashin PH; Graf W; Nygren P; Mahteme H
    Ann Surg Oncol; 2013 Dec; 20(13):4183-9. PubMed ID: 23975316
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytoreductive surgery and intraperitoneal chemotherapy for colorectal peritoneal carcinomatosis: prognosis and treatment of recurrences in a cohort study.
    Cashin PH; Graf W; Nygren P; Mahteme H
    Eur J Surg Oncol; 2012 Jun; 38(6):509-15. PubMed ID: 22475555
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Survival outcomes following primary tumor resection for patients with incurable metastatic colorectal carcinoma: Experience from a single institution.
    Lau JW; Chang HS; Lee KY; Gwee YX; Lee WQ; Chong CS
    J Dig Dis; 2018 Sep; 19(9):550-560. PubMed ID: 30117288
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Peritoneal carcinomatosis of colorectal origin: incidence and current treatment strategies.
    Koppe MJ; Boerman OC; Oyen WJ; Bleichrodt RP
    Ann Surg; 2006 Feb; 243(2):212-22. PubMed ID: 16432354
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Specific treatment situations in metastatic colorectal cancer].
    Arnold D; Schmoll HJ; Lang H; Knoefel WT; Ridwelski K; Trarbach T; Staib L; Kirchner T; Geissler M; Seufferlein T; Amthauer H; Riess H; Schlitt HJ; Piso P
    Onkologie; 2010; 33 Suppl 4():8-18. PubMed ID: 20431307
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical significance of primary tumor resection in colorectal cancer patients with synchronous unresectable metastasis.
    Kim MS; Chung M; Ahn JB; Kim CW; Cho MS; Shin SJ; Baek SJ; Hur H; Min BS; Baik SH; Kim NK
    J Surg Oncol; 2014 Aug; 110(2):214-21. PubMed ID: 24668581
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Unresectable peritoneal carcinomatosis from colorectal cancer: a single center experience.
    Hompes D; Boot H; van Tinteren H; Verwaal V
    J Surg Oncol; 2011 Sep; 104(3):269-73. PubMed ID: 21465492
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Curative cytoreductive surgery followed by hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinomatosis and synchronous resectable liver metastases arising from colorectal cancer.
    Lorimier G; Linot B; Paillocher N; Dupoiron D; Verrièle V; Wernert R; Hamy A; Capitain O
    Eur J Surg Oncol; 2017 Jan; 43(1):150-158. PubMed ID: 27839895
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic significance of visible cardiophrenic angle lymph nodes in the presence of peritoneal metastases from colorectal cancers.
    Elias D; Borget I; Farron M; Dromain C; Ducreux M; Goéré D; Honoré C; Boige V; Dumont F; Malka D; Pottier E; Caramella C
    Eur J Surg Oncol; 2013 Nov; 39(11):1214-8. PubMed ID: 24044805
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic Impact of Palliative Primary Tumor Resection for Unresectable Stage 4 Colorectal Cancer: Using a Propensity Score Analysis.
    Shida D; Hamaguchi T; Ochiai H; Tsukamoto S; Takashima A; Boku N; Kanemitsu Y
    Ann Surg Oncol; 2016 Oct; 23(11):3602-3608. PubMed ID: 27272107
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of prognostic factors in seventy patients having a complete cytoreduction plus perioperative intraperitoneal chemotherapy for carcinomatosis from colorectal cancer.
    da Silva RG; Sugarbaker PH
    J Am Coll Surg; 2006 Dec; 203(6):878-86. PubMed ID: 17116556
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The treatment of peritoneal carcinomatosis of colorectal cancer with complete cytoreductive surgery and hyperthermic intraperitoneal peroperative chemotherapy (HIPEC) with oxaliplatin: a Belgian multicentre prospective phase II clinical study.
    Hompes D; D'Hoore A; Van Cutsem E; Fieuws S; Ceelen W; Peeters M; Van der Speeten K; Bertrand C; Legendre H; Kerger J
    Ann Surg Oncol; 2012 Jul; 19(7):2186-94. PubMed ID: 22395983
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The American Society of Peritoneal Surface Malignancies (ASPSM) Multiinstitution Evaluation of the Peritoneal Surface Disease Severity Score (PSDSS) in 1,013 Patients with Colorectal Cancer with Peritoneal Carcinomatosis.
    Esquivel J; Lowy AM; Markman M; Chua T; Pelz J; Baratti D; Baumgartner JM; Berri R; Bretcha-Boix P; Deraco M; Flores-Ayala G; Glehen O; Gomez-Portilla A; González-Moreno S; Goodman M; Halkia E; Kusamura S; Moller M; Passot G; Pocard M; Salti G; Sardi A; Senthil M; Spilioitis J; Torres-Melero J; Turaga K; Trout R
    Ann Surg Oncol; 2014 Dec; 21(13):4195-201. PubMed ID: 24854493
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The modified Glasgow prognostic score for early mortality in patients with synchronous peritoneal carcinomatosis from colorectal cancer.
    Adachi T; Hinoi T; Hattori M; Egi H; Shimomura M; Saito Y; Sawada H; Miguchi M; Niitsu H; Mukai S; Yano T; Ohdan H
    Surg Today; 2015 Nov; 45(11):1396-403. PubMed ID: 25430811
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastasis in Norway: Prognostic factors and oncologic outcome in a national patient cohort.
    Frøysnes IS; Larsen SG; Spasojevic M; Dueland S; Flatmark K
    J Surg Oncol; 2016 Aug; 114(2):222-7. PubMed ID: 27173150
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association between palliative resection of the primary tumor and overall survival in a population-based cohort of metastatic colorectal cancer patients.
    Gresham G; Renouf DJ; Chan M; Kennecke HF; Lim HJ; Brown C; Cheung WY
    Ann Surg Oncol; 2014 Nov; 21(12):3917-23. PubMed ID: 24859937
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic significance of doubling time in patients undergoing radical surgery for metachronous peritoneal metastases of colorectal cancer.
    Miyake H; Murono K; Nagata H; Nozawa H; Kawai K; Hata K; Tanaka T; Nishikawa T; Shuno Y; Sasaki K; Ishihara S
    Int J Colorectal Dis; 2019 May; 34(5):801-809. PubMed ID: 30739186
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of ovarian metastases of colorectal and appendiceal carcinoma in the era of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
    Kuijpers AM; Mehta AM; Aalbers AG; van Driel WJ; Boot H; Verwaal VJ
    Eur J Surg Oncol; 2014 Aug; 40(8):937-42. PubMed ID: 24630923
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.